By 1937, infective endocarditis had long passed the milestones of pathological recognition, clinical identification, and bacteriological diagnosis. It was in the latter stages of being a progressively debilitating, incurably fatal disease that usually affected young people. Many of them were admitted repeatedly to hospital for treatment which was depressingly ineffective. I remember seeing such patients as a student and house physician, and how helpless one felt in the face of this unrelenting condition. Antibacterial treatment with sulphonamides was pointing the way towards eradicating infections of this kind but it rarely helped in endocarditis.
When penicillin became available towards the end of the second world war it was in very short supply. Indeed, in those early days, it used to be extracted from the urine of treated patients so that it could be re-administered. The dosage used was small by today's standards and treatment often had to be curtailed because supplies were so scarce. The earliest results of treating infective endocarditis were disappointing,' and it was not until 1944 that Loewe (more than 20 cases per million population). The incidence of infective endocarditis is about the same as it was in pre-antibiotic times.
The disease itself has changed in several ways.
One outstanding difference is in the age of patients in whom infective endocarditis occurs. In the 1930s 212 nearly two thirds of them were less than 40 years old. The age of patients has risen steadily so that infective endocarditis is now a disease of the middle aged and elderly.7 The main reason for this is the decline in rheumatic fever-nowadays few young people have rheumatic valve lesions, which are vulnerable to infection. The routine closure of patent ductus has also subtracted a considerable number of young people from those at risk. Improved standards of dental hygiene in children may well have lessened the risk of infection from this source. At the same time, the longer survival of an earlier generation of those with rheumatic heart disease, some of whom have undergone valve replacement, provides an aging population that is susceptible to infection. Whereas there are fewer infections of "rheumatic" mitral valves in young people, we now recognise that mitral valve prolapse is an important predisposing condition; and in older subjects degenerative changes in the mitral and aortic valves often seem to be important sites of infection. We have also come to realise that in many patients with infective endocarditis an affected valve was previously normal. A large and increasing number of patients have undergone valve replacement. Prosthetic valves have proved to be more vulnerable to infective endocarditis than the natural valves they replace. When prosthetic valve endocarditis occurs shortly after the operation it is usually a staphylococcal infection and mortality rates are high. An infection which occurs more than two months after operation (late prosthetic valve endocarditis) tends to be caused by the same organisms that infect natural valves.8 Such infection can usually be controlled, but there is the risk, peculiar to mechanical valves, of the prosthesis becoming obstructed and immobilised by vegetations. Cardiac surgery is not the only intervention that can be responsible for extraneous infection of a heart valve. Infection may follow haemodialysis for renal failure; it can happen after pacemaker implantation and in patients on prolonged intravenous medication. Infective endocarditis also affects drug addicts who use At the same time as antibiotic treatment of infective endocarditis became possible, antibiotic prophylaxis covering dental and other interventions became widely recommended-recommended but not necessarily practised. The facts that the incidence of infective endocarditis has hardly changed and that unprotected dental procedures and poor dental hygiene are still responsible for many cases of infective endocarditis speak for themselves.13 The introduction of adequate oral rather than intramuscular antibiotic cover should increase the proportion of protected dental procedures,'4 but unfortunately in many of those in whom infective endocarditis develops heart disease is not recognised before the procedure, and prophylaxis cannot be considered. It is possible, too, that in such a common condi'tion as mitral valve prolapse, the risk of infection may be outweighed by the risk of penicillin prophylaxis. When adequate antibiotic prophylaxis is given infective endocarditis rarely occurs. There are still many-unanswered questions as to who requires antibiotic prophylaxis and in what circumstances, and we still do not know the portal of entry of infection in most cases of infective endocarditis.
The continuing mortality from infective endo- 
